Related Experiment Videos
Characterization of a 4.8kb transcript from the Duchenne muscular dystrophy locus expressed in Schwannoma cells
D J Blake1, D R Love, J Tinsley
1Institute of Molecular Medicine, John Radcliffe Hospital, Headington, Oxford, UK.
Abstract:
The 14kb dystrophin transcript from the Duchenne muscular dystrophy (DMD) locus, which encodes a 427kDa protein, is differentially spliced at the amino terminal end giving rise to alternative transcripts expressed in muscle and brain. Here we present evidence for a 4.8kb transcript from the DMD locus which is ubiquitously expressed but is particularly abundant in Schwannoma cells where dystrophin could not be detected. The hybridisation of Western blots with dystrophin antibodies also identifies a protein of approximately 80kDa of variable abundance in different human and mdx tissues. Immunocytochemistry studies confirm the expression of this protein in nerve cells, a tissue in which full length dystrophin is not detected. Sequencing of the 5' end of a clone isolated from a rat Schwannoma cDNA library, shows that the 4.8kb transcript shares exons with the carboxy terminal end of dystrophin but the 5' untranslated region is not contained within the dystrophin transcript. We propose that the 4.8kb gene product be called apodystrophin-1 as its expression is distinct from the dystrophin 14kb mRNA but it is transcribed from the same locus.
Insights
Researchers discovered a new apodystrophin-1 transcript from the Duchenne muscular dystrophy (DMD) locus. This ubiquitous 4.8kb transcript is abundant in Schwannoma cells and expresses an 80kDa protein in nerve cells.
Area of Science:
- Molecular Biology
- Neuroscience
- Genetics
Background:
- The Duchenne muscular dystrophy (DMD) locus produces a 14kb dystrophin transcript encoding a 427kDa protein, with alternative splicing yielding muscle and brain-specific transcripts.
- Dystrophin is crucial for muscle function, and its absence or dysfunction leads to DMD.
- Previous research focused on the full-length dystrophin transcript and its role in muscle and brain.
Purpose of the Study:
- To investigate alternative transcripts originating from the DMD locus.
- To identify and characterize novel dystrophin-related proteins and their expression patterns.
- To explore the function and significance of a newly identified 4.8kb transcript.
Main Methods:
- Hybridization of Western blots with dystrophin antibodies.
- Immunocytochemistry studies on human and mdx tissues, including nerve cells.
- Sequencing of the 5' end of a clone from a rat Schwannoma cDNA library.
Main Results:
- Identification of a 4.8kb transcript from the DMD locus, ubiquitously expressed and abundant in Schwannoma cells.
- Detection of an approximately 80kDa protein, distinct from full-length dystrophin, in various human and mdx tissues, notably in nerve cells.
- Sequencing revealed the 4.8kb transcript shares exons with the carboxy-terminal end of dystrophin but has a unique 5' untranslated region.
Conclusions:
- The 4.8kb transcript, named apodystrophin-1, is a distinct gene product transcribed from the DMD locus.
- Apodystrophin-1 expression is independent of the full-length dystrophin 14kb mRNA, suggesting a separate functional role.
- The presence of apodystrophin-1 in nerve cells indicates a potential role in neuronal function or support, separate from dystrophin's known muscular functions.